Literature DB >> 17503220

Responsiveness to change [corrected] due to supportive-expressive group therapy, improvement in mood and disease progression in women with metastatic breast cancer.

Julie Lemieux1, Dorcas E Beaton, Sheilah Hogg-Johnson, Louise J Bordeleau, Jon Hunter, Pamela J Goodwin.   

Abstract

OBJECTIVE: To compare the responsiveness of six questionnaires using three hypotheses of change: (i) change due to supportive-expressive group therapy (SEGT), (ii) improved mood defined as a small effect size (.2) on Profile of Mood States (POMS) Total Mood Disturbance score and (iii) progression of disease.
METHOD: Data from the "Breast Expressive-Supportive Therapy" study, a multicentre randomized controlled trial of change due to SEGT versus standard of care in women with metastatic breast cancer were used. Questionnaires studied were: POMS, Impact of Event Scale, Psychosocial Adjustment to Illness Scale (PAIS), EORTC QLQ-C30, Mental Adjustment to Cancer and a Pain visual analog scale (VAS). Responsiveness to change was evaluated using the standardized response mean. POMS was used as the standard.
RESULTS: POMS was the most responsive questionnaire to change due to SEGT. Questionnaires measuring psychosocial attributes were responsive to improvement in mood. EORTC QLQ-C30, PAIS, PAIN VAS and MAC were the most responsive to disease progression. More responsive questionnaires were associated with the smallest sample size required to detect an effect.
CONCLUSIONS: Responsiveness to change is context specific. The POMS was the most responsive questionnaire to psychosocial therapy.

Entities:  

Mesh:

Year:  2007        PMID: 17503220     DOI: 10.1007/s11136-007-9208-2

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  35 in total

1.  Comparison of 2 quality-of-life questionnaires in women treated for breast cancer: the RAND 36-Item Health Survey and the Functional Living Index-Cancer.

Authors:  Rick W Wilson; Lorraine M Hutson; Deborah Vanstry
Journal:  Phys Ther       Date:  2005-09

Review 2.  The clinical significance of adaptation to changing health: a meta-analysis of response shift.

Authors:  Carolyn E Schwartz; Rita Bode; Nicholas Repucci; Janine Becker; Mirjam A G Sprangers; Peter M Fayers
Journal:  Qual Life Res       Date:  2006-09-26       Impact factor: 4.147

3.  Depression in palliative care patients--a prospective study.

Authors:  M Lloyd-Williams; T Friedman
Journal:  Eur J Cancer Care (Engl)       Date:  2001-12       Impact factor: 2.520

Review 4.  Assessing the responsiveness of a functional status measure: the Sickness Impact Profile versus the SIP68.

Authors:  A F de Bruin; J P Diederiks; L P de Witte; F C Stevens; H Philipsen
Journal:  J Clin Epidemiol       Date:  1997-05       Impact factor: 6.437

5.  A methodological framework for assessing health indices.

Authors:  B Kirshner; G Guyatt
Journal:  J Chronic Dis       Date:  1985

6.  Psychological distress in cancer patients with advanced disease.

Authors:  S Kaasa; U Malt; S Hagen; E Wist; T Moum; A Kvikstad
Journal:  Radiother Oncol       Date:  1993-06       Impact factor: 6.280

7.  Women with breast cancer: perception of family functioning and adjustment to illness.

Authors:  L C Friedman; P E Baer; D V Nelson; M Lane; F E Smith; R J Dworkin
Journal:  Psychosom Med       Date:  1988 Sep-Oct       Impact factor: 4.312

8.  Psychiatric disorder in women with early stage and advanced breast cancer: a comparative analysis.

Authors:  David W Kissane; Brenda Grabsch; Anthony Love; David M Clarke; Sidney Bloch; Graeme C Smith
Journal:  Aust N Z J Psychiatry       Date:  2004-05       Impact factor: 5.744

9.  Randomized, controlled trial investigating short-term health-related quality of life with doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: European Organization for Research and Treatment of Cancer Breast Cancer Group, Investigational Drug Branch for Breast Cancer and the New Drug Development Group Study.

Authors:  Andrew Bottomley; Laura Biganzoli; Tanja Cufer; Robert E Coleman; Corneel Coens; Fabio Efficace; Hilary Allan Calvert; Teresa Gamucci; Chris Twelves; Pierre Fargeot; Martine Piccart
Journal:  J Clin Oncol       Date:  2004-07-01       Impact factor: 44.544

10.  Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire.

Authors:  M J Hjermstad; S D Fossa; K Bjordal; S Kaasa
Journal:  J Clin Oncol       Date:  1995-05       Impact factor: 44.544

View more
  2 in total

Review 1.  A review and recommendations for optimal outcome measures of anxiety, depression and general distress in studies evaluating psychosocial interventions for English-speaking adults with heterogeneous cancer diagnoses.

Authors:  Tim Luckett; Phyllis N Butow; Madeleine T King; Mayumi Oguchi; Gaynor Heading; Nadine A Hackl; Nicole Rankin; Melanie A Price
Journal:  Support Care Cancer       Date:  2010-07-02       Impact factor: 3.603

2.  Effects of Yoga in Managing Fatigue in Breast Cancer Patients: A Randomized Controlled Trial.

Authors:  H S Vadiraja; Raghavendra Mohan Rao; R Nagarathna; H R Nagendra; Shekhar Patil; Ravi B Diwakar; H P Shashidhara; K S Gopinath; B S Ajaikumar
Journal:  Indian J Palliat Care       Date:  2017 Jul-Sep
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.